Treasure Valley Prostate Cancer Support

Beyond the Diagnosis: Nurturing Your Mental, Physical & Emotional Well-being Through Prostate Cancer.

Videos & Webinars | ZERO Prostate Cancer ZERO has a large library of educational webinars and videos touching on topics related to prostate cancer from treatment, side effects, research and more related to prostate cancer.

Bone health is very important and you should talk to your healthcare provider if you are on androgen depravation therapy. The standby treatments are Xgeva, Prolia, or zoledronic acid. Another drug, a biosimilar from Sandoz, has entered the field - Wyost or Jubbonth.

Sandoz receives FDA approval for first and only denosumab biosimilars | Sandoz Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) approved Wyost® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz), the first and only FDA-approved denosumab biosimilars, to treat all indications of the reference medicines.

I've had "posts" about this or that, but here is a link to materials at ZERO Prostate Cancer that gives links to their prostate cancer information for all stages and for caregivers. Scroll through it. There is information from when to test, what to look for, what questions to ask, early and advanced. [One comment: you will see that NCCN after age 75 does not recommend PSA test - THAT'S ONLY IF YOU'VE BEEN TESTING, following the guidelines, up until then. If you have not been tested - get tested!]

Educational Materials & Free PDF Downloads | ZERO Prostate Cancer Prostate cancer brochures, pamphlets, and fact sheets, free for you to download or request by mail. Educational materials are categorized by prostate cancer stages, specific topics, audiences and interest categories, and more. We add new documents on a regular basis.

This from PCF (Prostate Cancer Foundation)
Research Talks: Progress in Advanced Prostate Cancer Treatment

There is hopeful news for patients with metastatic prostate cancer: men live longer when they are treated with combination therapy, standard hormone therapy plus a newer drug called an androgen receptor pathway inhibitor. PCF Young Investigator Dr. Martin Schoen discusses his latest research.

Research Conversations: Better Treatments for Metastatic Prostate Cancer Medical oncologist and PCF-funded Young Investigator Dr. Martin Schoen discusses a recent publication supported by his 2022 Young Investigator Award. Combination therapy refers to adding another medicine (an androgen receptor pathway inhibitor [ARPI] or chemotherapy) to standard hormone therapy. Vie...